Scott B. Ullem
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 4,676 | $80.50 | $376K | +8.4% |
| Apr 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 8,324 | $79.79 | $664K | +9.3% |
| Mar 11SEC | EWEdwards Lifesciences Corp | Sell Plan | 5,099 | $84.46 | $431K | +3.3% |
| Mar 11SEC | EWEdwards Lifesciences Corp | Sell Plan | 7,901 | $85.21 | $673K | +2.4% |
| Dec 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 7,700 | $84.47 | $650K | +3.3% |
| Nov 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 2,974 | $83.30 | $248K | +4.7% |
| Nov 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 10,026 | $83.02 | $832K | +5.1% |
- Sell
CFO Scott B. Ullem sold $376K of EW at $80.50 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $664K of EW at $79.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $431K of EW at $84.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $673K of EW at $85.21 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $650K of EW at $84.47 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $248K of EW at $83.30 — pre-scheduled 10b5-1 plan sale.